STAT1 and diffuse large B-cell lymphoma: In addition, the expression of PARP9 is regulated by the IFNγ-JAK2/STAT1-IRF1 signaling axis that is required for cancer cell survival in diffuse large B-cell lymphoma (DLBCL) with an active host inflammatory response72.